Skip to Main Content

Paper Details

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
RMD Open
17
2022
COVID-19, Participants, SARD, SARDs, autoimmune rheumatic diseases, osteoarthritis, people, rheumatoid arthritis, systemic autoimmune rheumatic diseases
Author NameAffiliation
Rebecca GraingerUniversity of Otago Wellington
Zachary S WallaceHarvard Medical School
Zachary S WallaceClinical Epidemiology Program and Rheumatology Unit, Massachusetts General Hospital
Jasvinder A SinghUniversity of Alabama at Birmingham
Jasvinder A SinghBirmingham Veterans Affairs Medical Center
  • 1 - 5

Datasets

Release 1.2